Fundz

Bactana Corp. reported raising $385,000 in an initial SEC Form D filing, from an offering of $600,000

PRIVATEJul 07, 2022$385K of $600K raised

Amount Raised

$385,000

$385,000 sold, per SEC Form D (first sale Jul 7, 2022)

Round Type

Seed

FarmingtonBiotechnologyHealth Care

Quick answer

Bactana raised $385,000 in a Seed round, dated July 7, 2022. Bactana is based in Farmington, Connecticut, United States.

How much did Bactana raise?
Bactana raised $385,000 in a Seed round on July 7, 2022.
What does Bactana do?
Bactana is a development stage animal health company formed in collaboration with Cornell University.
Where is Bactana based and how big is it?
Bactana is based in Farmington, Connecticut, United States. Fundz records about 5 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Bactana that raised within 45 days of this round, from Fundz verified event records.

  • Kymera raised $150M (Post-IPO Equity) on August 19, 2022.
  • Rivus Pharmaceuticals raised $66M on August 19, 2022.
  • Inherent Biosciences raised $1.5M (Seed) on August 19, 2022.
  • AIRS Medical raised $20M (Series B) on August 19, 2022.
  • Trial Library raised an undisclosed amount (Seed) on August 18, 2022.
  • Vergent Bioscience raised $22M on August 17, 2022.

Who to call at Bactana, and when

A new round usually means Bactana is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bactana raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bactana, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bactana. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bactana

Location

CELL & GENOMICS BUILDING

Farmington, Connecticut, United States

About

Bactana is a development stage animal health company formed in collaboration with Cornell University. We have patented the use of a select group of microbes that manipulate the microbial ecology of animals to enhance the interaction of the microbiome, immune system, and metabolism (immunometabolism). We are creating therapies for pets to treat metabolic conditions and digestive disorders, while also developing sustainable products for use in livestock production that reduce natural resource utilization, greenhouse gas emissions, and antibiotic usage.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bactana raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bactana's next move

See what Strategic adds

Bactana raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.